Last updated 2026-06-18
Total raised
—
Stage
Pre-Funding
Founded
2021
Headcount
1
HQ
Petah Tikva, Israel
Sector
Health Tech & Life Sciences
About
BioPass Pharma is developing a revolutionary formulation intended for the treatment of brain or CNS diseases utilizing its patented novel technology, which is designed to deliver molecules directly into the brain by bypassing the BBB.
Its novel nasal formulation offers short onset of a non-invasive, painless, easily administered treatment, avoiding gastrointestinal and hepatic presystemic metabolism.
BioPass Pharma has secured exclusive rights for this technology from the Hebrew University of Jerusalem.
Q&A
- What is BioPass Pharma's primary focus?
- BioPass Pharma is focused on developing a revolutionary formulation for treating brain or CNS diseases by delivering molecules directly into the brain, bypassing the blood-brain barrier (BBB).
- What technology does BioPass Pharma utilize?
- BioPass Pharma utilizes a patented novel technology for drug delivery, specifically a nasal formulation designed for non-invasive, painless, and easily administered treatment.
- From where did BioPass Pharma secure its core technology rights?
- BioPass Pharma secured exclusive rights for its core technology from the Hebrew University of Jerusalem.
- When was BioPass Pharma founded?
- BioPass Pharma was founded in October 2021.
- What is BioPass Pharma's current employee count?
- BioPass Pharma has 1-10 employees.
- In which sector does BioPass Pharma primarily operate?
- BioPass Pharma primarily operates in the Health Tech & Life Sciences sector, with specializations in Pharma & Medical Biotechnology and Drug Delivery.
- What is the current funding stage of BioPass Pharma?
- BioPass Pharma is currently in the Pre-Funding stage.
- Does BioPass Pharma hold any patents?
- Yes, BioPass Pharma holds one patent related to its technology.
Team · 4
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Technologies
Materials & SubstancesNanomaterials
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyHealthcarePatients
Business model
B2B
Highlights
1 PatentsVerified
Tags
cns-disordersdrug-discoverytargeted-therapydrug-deliverynon-invasivepharmaceuticalsnanotechnology
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| linkedin.com/company/94165392 |
Identifiers & details
| Founded | 2021-10 |
|---|---|
| Employees (exact) | 1 |